The science behind the peptide craze Scientific American FDA Peptide Reclassification 2026: What It Means for Providers An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Ipamorelin: Benefits, Dosage & Risks (2025) Huddle Men's Health FDA's Overreach on Compounded Peptides New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then,